[Inhibition of anabolic effect of methenolone on renal tissue by beta-pyridylcarbinol].
D000085:Acetates; D045930:Anabolic Agents / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D002452:Cell Count; D004247:DNA / Q000032:analysis*; D003864:Depression, Chemical; D005260:Female; D007668:Kidney / Q000032:analysis* / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects; D008710:Methenolone / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D051379:Mice; D009929:Organ Size; D011506:Proteins / Q000032:analysis*; D011725:Pyridines / Q000494:pharmacology*; D012313:RNA / Q000032:analysis*; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000494:pharmacology*
D000085:Acetates; D045930:Anabolic Agents; D011506:Proteins; D011725:Pyridines; D014665:Vasodilator Agents; D012313:RNA; D004247:DNA; D008710:Methenolone
Die Hemmung der anabolen Wirkung von Metenolon auf Nierengewebe durch beta-Pyridylcarbinol.